

Author: Raymond Timothy Raymond Russell Lincoff A Michael
Publisher: Future Medicine
ISSN: 1479-6678
Source: Future Cardiology, Vol.9, Iss.3, 2013-05, pp. : 387-403
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Diabetes mellitus is a metabolic disease with microvascular and macrovascular complications, and is well known to increase the risk of coronary atherosclerosis. Despite recent reductions in the prevalence of coronary artery disease and cardiovascular events in the USA, persons with diabetes remain up to four-times as likely to die of cardiovascular disease than the general population. Diabetes is associated with an atherogenic lipid profile, induces a hypercoagulable state, and increases coronary plaque volume, progression and instability. Medicinal and procedural treatments in the patient with diabetes should be multifactorial, targeting and managing the many coexisting risk factors that contribute to atherosclerosis. This type of treatment is complex and should be individualized, and guided by a careful review of recent literature. Here we discuss important clinical data and their impact on up-to-date recommendations for the management of coronary artery disease in the patient with Type 2 diabetes mellitus.
Related content


Coronary artery disease screening in patients with diabetes
Endocrine Journal, Vol. 33, Iss. 3, 2008-06 ,pp. :


Erectile Dysfunction and Coronary Artery Disease in Patients with Diabetes
Current Diabetes Reviews, Vol. 7, Iss. 2, 2011-01 ,pp. :


Diagnosis and Management of Chronic Coronary Artery Disease
Current Cardiology Reviews, Vol. 3, Iss. 3, 2007-08 ,pp. :


Future strategies in the management of coronary artery disease
Future Cardiology, Vol. 2, Iss. 5, 2006-09 ,pp. :